X4 Pharmaceuticals (XFOR) Other Accumulated Expenses (2017 - 2019)
X4 Pharmaceuticals (XFOR) posted Other Accumulated Expenses of $280000.0 for Q2 2019, up 3.32% on a QoQ basis from $271000.0 in Q1 2019, and down 36.65% year-over-year from $442000.0 in Q2 2018.
X4 Pharmaceuticals (XFOR) Other Accumulated Expenses (2017 - 2019) Analysis & Trends
X4 Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $280000.0 for Q2 2019.
- Quarterly Other Accumulated Expenses fell 36.65% year-over-year to $280000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $280000.0 (down 36.65% YoY) and the FY2018 annual result came in at $249000.0, down 50.0% from the prior year.
- Other Accumulated Expenses was $280000.0 for Q2 2019 at X4 Pharmaceuticals, up from $271000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $498000.0 in Q4 2017 and bottomed at $249000.0 in Q4 2018.
- A 3-year average of $361857.1 and a median of $386000.0 in 2018 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2018 — Other Accumulated Expenses plunged 50.0% — and 2019, when it tumbled 33.42%.
- X4 Pharmaceuticals' Other Accumulated Expenses stood at $498000.0 in 2017, then plunged by 50.0% to $249000.0 in 2018, then gained by 12.45% to $280000.0 in 2019.
- Business Quant data shows XFOR's Other Accumulated Expenses at $280000.0 in Q2 2019, $271000.0 in Q1 2019, and $249000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 280,000.00 |
| Mar 31, 2019 | 271,000.00 |
| Dec 31, 2018 | 249,000.00 |
| Sep 30, 2018 | 386,000.00 |
| Jun 30, 2018 | 442,000.00 |
| Mar 31, 2018 | 407,000.00 |
| Dec 31, 2017 | 498,000.00 |